133 related articles for article (PubMed ID: 1691960)
1. The thyroid stimulating hormone receptor in human disease.
Harrison LC; Leedman PJ
Clin Biochem; 1990 Feb; 23(1):43-8. PubMed ID: 1691960
[TBL] [Abstract][Full Text] [Related]
2. Human thyrotropin receptor subunits characterized by thyrotropin affinity purification and western blotting.
Leedman PJ; Newman JD; Harrison LC
J Clin Endocrinol Metab; 1989 Jul; 69(1):134-41. PubMed ID: 2471709
[TBL] [Abstract][Full Text] [Related]
3. Clinical applications of TSH receptor antibodies in thyroid diseases.
Cho BY
J Korean Med Sci; 2002 Jun; 17(3):293-301. PubMed ID: 12068130
[TBL] [Abstract][Full Text] [Related]
4. Autoantibodies to the thyrotropin receptor.
Rees Smith B; McLachlan SM; Furmaniak J
Endocr Rev; 1988 Feb; 9(1):106-21. PubMed ID: 3286231
[TBL] [Abstract][Full Text] [Related]
5. Interaction of thyroid-stimulating antibody with Graves' thyroid-stimulating hormone-binding antibody.
Ochi Y; Kajita Y; Hamazu M; Nagata A
Horm Res; 2003; 59(5):222-8. PubMed ID: 12714785
[TBL] [Abstract][Full Text] [Related]
6. Thyrotropin receptor antibodies in hypothyroid Graves' disease.
Kasagi K; Hidaka A; Nakamura H; Takeuchi R; Misaki T; Iida Y; Konishi J
J Clin Endocrinol Metab; 1993 Feb; 76(2):504-8. PubMed ID: 8094394
[TBL] [Abstract][Full Text] [Related]
7. Stimulating and blocking thyroid-stimulating hormone (TSH) receptor autoantibodies from patients with Graves' disease and autoimmune hypothyroidism have very similar concentration, TSH receptor affinity, and binding sites.
Morgenthaler NG; Ho SC; Minich WB
J Clin Endocrinol Metab; 2007 Mar; 92(3):1058-65. PubMed ID: 17179194
[TBL] [Abstract][Full Text] [Related]
8. Anti-TSH antibodies in Graves' disease and their failure to interact with TSH receptor antibodies.
Ochi Y; Nagamune T; Nakajima Y; Ishida M; Kajita Y; Hachiya T; Ogura H
Acta Endocrinol (Copenh); 1989 Jun; 120(6):773-7. PubMed ID: 2567103
[TBL] [Abstract][Full Text] [Related]
9. Further characterization of a high affinity thyrotropin binding site on the rat thyrotropin receptor which is an epitope for blocking antibodies from idiopathic myxedema patients but not thyroid stimulating antibodies from Graves' patients.
Kosugi S; Ban T; Akamizu T; Kohn LD
Biochem Biophys Res Commun; 1991 Oct; 180(2):1118-24. PubMed ID: 1719963
[TBL] [Abstract][Full Text] [Related]
10. TSH receptor antibody-associated thyroid dysfunction following subacute thyroiditis.
Iitaka M; Momotani N; Hisaoka T; Noh JY; Ishikawa N; Ishii J; Katayama S; Ito K
Clin Endocrinol (Oxf); 1998 Apr; 48(4):445-53. PubMed ID: 9640411
[TBL] [Abstract][Full Text] [Related]
11. Anti-TSH receptor antibodies in clinical practice.
Orgiazzi J
Endocrinol Metab Clin North Am; 2000 Jun; 29(2):339-55, vii. PubMed ID: 10874533
[TBL] [Abstract][Full Text] [Related]
12. [Analysis of epitopes for TSH receptor autoantibodies using TSH receptor/LH-CG receptor chimeras].
Tahara K; Yamamoto K; Tamura Y; Yoshida S
Nihon Rinsho; 1994 Apr; 52(4):1031-6. PubMed ID: 7515118
[TBL] [Abstract][Full Text] [Related]
13. Epitope mapping of tsh receptor-blocking antibodies in Graves' disease that appear during pregnancy.
Kung AW; Lau KS; Kohn LD
J Clin Endocrinol Metab; 2001 Aug; 86(8):3647-53. PubMed ID: 11502791
[TBL] [Abstract][Full Text] [Related]
14. The thyroid "microsomal" antigen is an epitope on the thyrotropin receptor.
Islam N; Tuppal R; Hawe BS; Briones-Urbina R; Farid NR
J Cell Biochem; 1986; 31(2):107-20. PubMed ID: 2426288
[TBL] [Abstract][Full Text] [Related]
15. The extracellular domain of the TSH receptor has an immunogenic epitope reactive with Graves' IgG but unrelated to receptor function as well as determinants having different roles for high affinity TSH binding and the activity of thyroid-stimulating autoantibodies.
Kosugi S; Akamizu T; Takai O; Prabhakar BS; Kohn LD
Thyroid; 1991; 1(4):321-30. PubMed ID: 1726785
[TBL] [Abstract][Full Text] [Related]
16. Limitations of the semisynthetic library approach for obtaining human monoclonal autoantibodies to the thyrotropin receptor of Graves' disease.
Van Der Heijden JH; De Bruin TW; Glaudemans KA; De Kruif J; Banga JP; Logtenberg T
Clin Exp Immunol; 1999 Nov; 118(2):205-12. PubMed ID: 10540180
[TBL] [Abstract][Full Text] [Related]
17. TSH-receptor autoantibodies - differentiation of hyperthyroidism between Graves' disease and toxic multinodular goitre.
Wallaschofski H; Kuwert T; Lohmann T
Exp Clin Endocrinol Diabetes; 2004 Apr; 112(4):171-4. PubMed ID: 15127319
[TBL] [Abstract][Full Text] [Related]
18. Monoclonal antibodies to the thyrotropin receptor raised by an autoantiidiotypic protocol and their relationship to monoclonal autoantibodies from Graves' patients.
Hill BL; Erlanger BF
Endocrinology; 1988 Jun; 122(6):2840-50. PubMed ID: 2453350
[TBL] [Abstract][Full Text] [Related]
19. Characteristics of anti-TSH receptor antibodies in two patients who developed spontaneous hypothyroidism after antithyroid drug therapy for hyperthyroid Graves' disease.
Kaise K; Kaise N; Yoshida K; Itagaki Y; Yamamoto M; Sakurada T; Saito S; Yoshinaga K
Tohoku J Exp Med; 1987 Jul; 152(3):269-75. PubMed ID: 3660401
[TBL] [Abstract][Full Text] [Related]
20. Administration of thyroxine in treated Graves' disease. Effects on the level of antibodies to thyroid-stimulating hormone receptors and on the risk of recurrence of hyperthyroidism.
Hashizume K; Ichikawa K; Sakurai A; Suzuki S; Takeda T; Kobayashi M; Miyamoto T; Arai M; Nagasawa T
N Engl J Med; 1991 Apr; 324(14):947-53. PubMed ID: 1900575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
